There’s a popular theory in the punk rock community, that the best music is made in the worst times. Could the same apply to the work of the health economics and outcomes research (HEOR) community? ISPOR is by no means… Read More »Meeting round-up: ISPOR Annual 2022
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 14th October 2019
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 18th December 2017
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources… Read More »Chris Sampson’s journal round-up for 1st August 2016
Personalised medicine appears to be an inevitable future of health care, and economists aren’t ready for it. It has various monikers and related concepts including precision medicine, stratified medicine, pharmacogenomics, pharmacogenetics and predictive medicine. But, whatever you call it, it means big… Read More »Economics of personalised medicine: an introduction
I’m currently reading Les Mis (I have been for about 2 years – it’s half a million words long). A few months ago, Hugo described economists to me as “geologists of politics” (géologues de la politique). A pretty smart observation… Read More »Some thoughts on evidence-based policy
